Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.05 USD | +5.44% | +8.95% | +55.85% |
Apr. 23 | Edgewise Therapeutics Secures Orphan Drug Designations for Sevasemten in EU | MT |
Apr. 22 | RBC Raises Price Target on Edgewise Therapeutics to $32 From $28, Keeps Outperform, Speculative Risk | MT |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Other languages